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ABSTRACT 
The purpose of this review is to present some concepts on 
the etiology of tropical spastic paraparesis or human T-cell lym- 
photropic virus-l (HTLV-I)-associated myelopathy (TSP/HAM). 
The large number of syndromes that have been associated 
with HTLV-I (60 to date), the existence of TSP/HAM cases 
associated with other retroviruses (human immunodeficiency 
virus-2 [HIV-21, HTLV-II), the existence of many TSPs without 
HTLV-I, and the evidence of clear epidemiologic contradictions 
in TSP/HAM indicate that the etiopathogenesis of TSP/HAM is 
not yet clear. Tropical spastic paraparesis/HAM affects patients 
of all human ethnic groups, but usually in well localized and rel- 
atively isolated geographic regions where HTLV-I has been 
endemic for a long time. Environmental factors and geographic 
locations appear to be critical factors. Because the neuro- 
pathology of TSP/HAM suggests a toxometabolic, rather than 
a viral cause, it is proposed that an intoxication similar to neuro- 
lathyrism could account for some of TSP/HAM cases, mainly 
in tropical and subtropical countries. If this were the case, 
HTLV-I could be a cofactor or act as a bystander. it is possi- 
ble that co-infection with another agent is necessary to produce 
TSP/HAM and most of the syndromes associated with HTLV-I. 
Key words: cofactors, environmental, HIV-l, HTLV-I, 
HTLV-l-associated myelopathL: HTLV-II, myelopathL: tropical 
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In 1969, the term tropical spastic paraparesis (TSP) was 
intr0duced.l These authors discussed the strong possi- 
bility that a slow virus was involved in this perplexing dis- 
order found in India and Jamaica. Most cases used to 
come from predominantly rural areas, which raised the 
possibility of a viral reservoir in mammals or fowl. In 
1981, the first endemic focus of TSP in continental Amer- 
ica in the South Pacific coast of Colombia was reported.’ 
At that time the relation of human T-cell lymphotropic 
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virus-1 (HTLV-I) with this syndrome was unknown. Four 
years later, the association of TSP with HTLV-I in patients 
from Martinique was reported.3 The HTLV-I, a retrovirus, 
had been discovered in 1980 at the National Cancer Insti- 
tute of America.* Three months after the pioneering pub- 
lication from Martinique, a group consisting of North 
American, Jamaican, and Colombian investigators con- 
firmed the French findings in serum and in cerebrospinal 
fluid (CSF) of patients with TSP from the south Pacific 
coast of Colombia and from Jamaica.5 Four months after 
that publication, Japanese investigators described the asso- 
ciation of HTLV-I with spinal spastic paraparesis (SSP), a 
syndrome with characteristics similar to those of TSI? 
This group, from Kagoshima, a city located on the island 
of Kyushu (southern Japan), named the syndrome HAM 
(HTLV-I-associated myelopathy). The author proposed 
the term RAMS (retroviruses-associated myelo- 
neuropathies) for both syndromes, TSP and HAM.’ The 
World Health Organization Health Committee recom- 
mended the use of the conciliatory term TSP/HAM.8 
Since 1985, many cases of TSP associated with HTLV- 
I have been reported around the world: Martinique, 
Jamaica, the south Pacific coast of Colombia, Ecuador, 
Trinidad and Tobago, Dominican Republic, Seychelles, 
Brazil, Zaire (DRC), and Florida (southern USA) are, so 
far, the most endemic tropical and subtropical regions of 
TSP in the world. Japan, a nontropical country, is, after 
Brazil, the country with the highest incidence of 
TSP/HAM. In Japan most TSP/HAM patients live or have 
lived in the southern islands (Kyushu, Shikoku) and in 
subtropical Okinawa.9 By defmition, all HAM cases (100%) 
are associated with HTLV-I. 
CLINICAL SPECTRUM OF HTW-I 
Human T-cell lymphotropic virus-1 has been considered 
the cause of adult T-cell leukemia-lymphoma (ATLL),” 
and also has been associated with polymyositis,“B12 arthri- 
tis 13x1* uveitis,15-l7 idiopathic thrombocytopenic pur- 
p&a, I8 Sjiigren syndrome,19 infective dermatitis,20,21 
chronic prostatitis and interstitial cystitis,22 lymphocytic 
alveolitis,23~24 hypereosinophilic syndromes,25 pseudo- 
amyothrophic lateral sclerosis,z6,27 lymphocytic meningi- 
tis,‘* Hashimoto thyroiditis,29 xerosis and erythema,30 
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increased malignancy of cervix and vaginal cancer3i 
inflammatory peripheral neuropathies,32 demyelinating 
neuropathies,33 atypical lumboradiculopathies,34 and Guil- 
lain-Barre35 facial nerve palsy,36 persistent lympha- 
denopathy,37 retinal vasculitis,38 pigmentary retinal 
degeneration, 39 chronic polyradiculoneuritis,26 necrotizing 
vasculitis of the skir~,*~ crusted (Norwegian) scabiosis,*l 
accelerated progression of uterine cancer,** malignant 
fibrous histiocytoma,43 multiple sclerosis,** Behcet dis- 
ease,45 multiple system atrophy,46 pseudohypoparathy- 
roidism,*’ monoclonal gammopathy and chronic renal 
failure,** strongyloidiasis,49 dermatopolymyositis,50 chronic 
dacryosialadenitis,51 hyperthyroidism, hypothyroidism, M 
proteinemia multiple myeloma and mild subcortical 
dementia,9 cranial polineuritis, bulbar palsy, and basal gan- 
glia syndromes,** primary biliary cirrhosis,52 familial or 
hereditary spastic paraparesis,53,54 rhombencephalitis,55,56 
dementia,57 neuropsychological disorders,58 primary scle- 
rosing cholangitis,59 folliculitis decalvans, cranial pachy- 
meningitisbl myasthenia gravis,62 progressive flaccid 
myelopathy,” cerebellar syndrome,64 systemic lupus ery- 
thematosus,65 and most recently, in Canada, with periph- 
eral neuropathy associated with cerebral white matter 
lesions in the absence of spastic paraparesis.” Fortunately, 
schizophrenia was not conclusively associated with HTLV- 
I.67 These numerous and heterogeneous associations cast 
some doubt on the causal association of HTLV-I with all 
these syndromes and diseases. 
OTHER RETROVIRUSES 
ASSOCIATED WITH TSP/HAM 
In 1987, a 32-year-old man from Ivory Coast with TSP 
was found to have both, HTLV-I and HTLV-IV (HIV-2). This 
was the first reported case of tropical spastic parapare- 
sis associated with dual exposure to retroviruses.68 The 
authors emphasized that retroviral polyinfections also 
could result in an increase of neurologic complications 
in Africa and that concomitant infections with two types 
of retrovirus may lead to new forms of neoplastic trans- 
formation. In 1988, a second patient, a 31-year-old man 
(also from Ivory Coast), was found to have TSP associated 
with HIV-2 only.69 
In 1991, in Fukuoka, Japan, located on HTLV-I-en- 
demic Kyushu island, 12 of 18 (67%) TSP/HAM patients 
were co-infected with HTLV-I and HTLV-II.” This report 
has been controverted by other Japanese investigators. 
One year later, two HTLV-II seropositive Amerindian sis- 
ters from New Mexico with a TSP/HAM-like syndrome 
(olivopontocerebellar atrophy), a variant of multiple- 
system atrophy, were reported.‘l 
In 1993, HTLV-II was isolated in the absence of any 
other detectable human retrovirus in a 52-year-old black 
man with TSP/HAM from Baltimore.73 In the same year, 
a 54-year-old black Bahamian woman with spastic ataxia, 
a similar illness to TSP/HAM was found to have HTLV-II, 
serologically, by polymerase chain reaction (PCR) and by 
viral culture.73 In 1995, several patients with ataxic 
myelopathies (another TSP/HAM-like syndrome) associ- 
ated with HTLV-II from Pot-to Alegre (southeast Brazil) 
were described.‘* These publications implicated differ- 
ent retroviruses in the pathogenesis of TSP/HAM and 
similar myelopathies. 
TSP/HAM AFTER TRANSFUSION 
The rapid development of myelopathy after blood trans- 
fusions to a cardiac transplant patient in France, appar- 
ently demonstrated the causal relation among HTLV-I and 
TSP/HAM.75 It must be considered that this patient 
received blood components from 59 donors and that only 
HIV-l, herpes simplex virus types 1 and 2, cytomegalo- 
virus, Epstein-Barr virus, and hepatitis B virus were inves- 
tigated. The HTLV-I-seropositive donor was a healthy 
woman from the French West Indies in the Caribbean, a 
well-known HTLV-I-endemic area. At that time it was 
believed that such a case represented indisputable proof 
that HTLV-I was the only cause of TSP/HAM, because 
HTLV-I was found in the blood used for the cardiac trans- 
plant and because the patient was HTLV-I seronegative 
before the heart transplant. Unfortunately, no molecular 
biology or immunology were performed in this case.76 It 
needs to be remembered that blood transfusions can 
transmit not only germs but also toxins and antibodies. 
HTLV-I-SEROPOSITIVE TSP/HAM 
VERSUS HTLV-I-SERONEGATIVE TSP 
The major international publications from 1985 to 1996 
on epidemiology of TSP were reviewed. Special empha- 
sis was given to the ratio of HTLV-I-seropositive and 
-seronegative TSPs.” The HTLV-I-associated myelopathy 
found in Japanese patients could not be compared to 
most of the world’s cases of TSPs because HAM, by def- 
inition, includes only cases of neurologic syndromes and 
diseases with seropositivity to HTLV-I. 
Countries with more than a 50% association of TSP 
with HTLV-I are: Martinique (59%, 78%) Jamaica (67%, 
83%) Colombia (73%, 87%) Trinidad and Tobago (100%) 
Seychelles (85%) Dominican Republic (85%) northeast- 
ern Brazil (71%) Ecuador (lOO%), Zaire (96%) and Panama 
(56%). Foreign blacks (Caribbean’s) living in New York 
also showed a high percentage (77%) of HTLV-I-seropos- 
itive TSPs. In the countries and regions with the larger 
proportion of seropositive TSPs, most patients lived in 
or came from rural areas of tropical countries, which sug- 
gests that environmental factors may be involved in the 
etiology of this syndrome. 
The percentage of HTLV-I seronegative TSPs was sur- 
prisingly high (more than 50%) among other tropical and 
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nontropical countries or regions: Chile (56%), northeast- 
ern Brazil (63%) eastern Brazil (64%) West Africa (74%) 
North American blacks living in New York (75%) Ivory 
Coast (SS%, S9%), Solomon Islands (S3%), Thailand 
(lOO%), Indian Ocean Islands (lOO%), Ethiopia (91%) 
Cuba (100%) Venezuela (56%) India (92%) and Egypt 
(86%). In Mexico, from 96 patients with spastic para- 
paresis of unknown cause, 96 (100%) were found to be 
HTLV-I seronegative (Sotelo J. Personal communication). 
Until the end of 1996, of the 2811 cases of TSP/HAM 
reported throughout the world, only 1261 (45%) were 
associated with HTLV-1.” 
It is well known that some seronegative TSP/HAMs 
are HTLV-I seropositive by PCR. From 10 HTLV-I-seroneg- 
ative TSP/HAM cases from Chile, the tax gene was ampli- 
fied from PBMN of five patients but Ztr was not detected 
in any patient. 79 Twelve seronegative TSPs tested by PCR 
in northeastern Brazil,” were persistently negative. In 
13 of 25 HTLV-I-seronegative TSPs, 4 patients (31%) were 
PCR positive. In cases from Colombia, most HTLV-I-sero- 
positive TSPs were black women from the Pacific coast, 
but most HTLV-I-seronegative TSPs were male mestizoes 
from the Andes region. 
The epidemiology of HTLV-I and TSP/HAM has been 
inconsistent, and the fact that HTLV-II has accounted for 
some HTLV-I-false-seropositive results in the past com- 
plicates the critical analysis of many of the initial epi- 
demiologic reports on TSP/HAM. 
CONTRADICTORY EPIDEMIOLOGY OF TSPBIAM 
Japan 
The Ainu population from Hokkaido have one of the 
highest HTLV-I-seroprevalence rates in the world 
(45%).81~82 However, there are no confirmed published 
cases of HAM among the Ainu.83 
In the Ryukyuans from Okinawa, HTLV-I seropreva- 
lence is higher (32.6%) than in Ryukyuans from south 
Kagoshima (11.7%). The prevalence of HAM is higher in 
Ryukyuans from south Kagoshima than in Ryukyuans 
from Okinawa.*’ 
Whereas in Tsushima Island (northwest of Kyushu) 
with 22.7% HTLV-I seroprevalence HAM cases are rare,** 
in south Kyushu, with a lower seroprevalence (11.7%), 
HAM cases frequently occur.*j 
Curiously, in Fukuoka, a city located a few hundred 
miles north of Kagoshima city, in the same HTLV-I- 
endemic Kyushu island, with a similar HTLV-I seropreva- 
lence and with equal genetic background, only 50% of SSP 
patients were HTLV-I seropositive.86 
Africa 
In Inongo (Zaire) (Democratic Republic of Congo), no 
TSP cases were found in the ethnic group Bolia with an 
HTLV-I seroprevalence of 6.5%, whereas in the ethnic 
group Ntomba, with a seroprevalence of 2.2%, six TSP 
cases were found.87 
In sub-Saharan Africa, a well-known reservoir of 
HTLV-I, with at least 5 million infected persons,@’ most 
TSPs are not related to HTLV-I infection.89 
Colombia 
In Tumaco (south Pacific coast of Columbia), blacks of 
African origin have only a 3.5% HTLV-I-seroprevalence 
rate; this same population has one of the highest rates of 
TSP in the world (98/100,000).90 On the north Pacific 
coast of Columbia, Waunama Emberas, Chamies, and 
Cunas Indians with HTLV-I seroprevalences of l%, 2%, 
and 15%, respectively, have not developed TSP91 
Western Pa&c Islands 
In the western Pacific islands, high prevalence rates of 
HTLV-I are found in isolated populations: Banks and Tor- 
res Islands: Vanua Levu (21%) Mera Lava (22%) Gaua 
(38%) Merig (41%) Hiu (47%) Loh (48%); New Guinean 
populations: Esep (26%) Arebunkara (27%) Obeimi (35%) 
and Waragu (50%) (the world’s highest reported rate); 
Solomon Islands: Santa Cruz (9%), Reef Island (11%) 
Vanikoro (14%) Bellona (21%).9z Most (83%) cases of idio- 
pathic spastic paraparesis were not associated with HTLV- 
I. Curiously among these HTLV-I carriers there was no 
evidence of historic contact with people from Japan or 
Africa.93 
Brazil 
Japanese immigrants (Okinawans, Ryukyuans), living in 
Camp0 Grande (Matto Gross0 do Sul) had 13% HTLV-I 
seroprevalence in 1986.94 Eleven years later there are no 
published cases of TSP/HAM among these “supposed 
genetically susceptible” Japanese descendants. 
EPIDEMIOLOGIC DATA SUGGESTING 
ENVIRONMENTAL COFACTORS IN TSP/HAM 
Caribbean 
The incidence in Martinique of TSP associated with HTLV- 
I ranges from 12 per 100,000 on the drier side of the 
island to 50 per 100,000 on the wetter side.95 
In TSP cases from Trinidad there appeared to be a 
relation to the proximity of watercourses, poor housing, 
and absence of a piped water supplyg6 
United States of America 
Most TSP cases in Florida and in New York (77%) are 
among immigrants of African descent from Haiti, Domini- 
can Republic, and Jamaica, working on small farms or as 
domestic servants.97,98 
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From 25 TSP/HAM cases found in the United States, 
92% (23/25) had become symptomatic while living in 
the United States.99 
NEUROPATHOLOGY OF TSP/HAM 
the extent and severity of the inflammation were most 
severe in the lower thoracic cord, and it tended to taper 
off gradually in both upward and downward directions. 
The paucity of inflammatory cells in the subarachnoidal 
space could be consistent with the clinical finding of 
mild or no pleocytosis in the CSE 
Here, the main neuropathologic findings of Iwasaki, 
Iwasaki from Sendai published an excellent book that 
included most autopsy cases of HAM in Japanloo In 1989, 
Liberski, and Cartier and colleagues are summarized.100-103 
Liberski et al, from the United States, reviewed the neuro- 
pathology of TSP in one woman from Jamaica and in one 
According to Iwasaki, the cardinal neuropathologic 
Caucasian manlo This publication included the electron 
microscopy findings of these two cases. In the same year, 
findings of HAM/TSP are histopathologic observations of 
Cartier, from Chile, compared the histopathology of three 
the spinal cord, the distribution of white matter degen- 
Chilean cases.iO* In 1997, the same author published the 
clinical and neuropathologic findings of six patients with 
spastic paraparesis associated with HTLV-I.lo3 In 1989, 
eration in the spinal cord, and lesions outside the spinal 
another book discussed most known autopsy cases of 
HAM, including the cases published by Iwasaki in 1988.104 
cord. 
Histopathologic Observations of the Spinal Cord 
The main feature of the neuropathologic changes in 
HAM/TSP was a chronic progressive inflammatory 
process preferentially involving the white and gray mat- 
ter of the spinal cord. 
Inflammatory Reactions 
The chronic inflammatory process of the white and gray 
matter of the spinal cord mainly affected the lateral 
funiculus. There were various degrees of glyomesenchy- 
ma1 tissue reactions. The inflammatory cell collection 
around small parenchymal vessels was almost always 
accompanied by a cellular exudation into the adjacent 
parenchymal tissues. Perivascular cuffs had formed mostly 
around small veins or venules, and the walls of these 
small vessels often were obscured by the overlying cel- 
lular exudates. However, perivascular cuffing of small 
arteries was not rare. Although cellular exudation 
occurred randomly in both the gray and white matter, it 
was more frequently seen in the deeper portion of the 
cord than in the surface areas. 
The lateral column was most extensively, and usually 
symmetrically involved in the inflammation, whereas the 
anterior column was affected irregularly and less severely. 
Inflammatory cell infiltration in the posterior column 
usually was mild, and was confined mostly to the ventro- 
median portion. Although the inflammatory process could 
be seen throughout the entire length of the spinal cord, 
The severity of inflammation in each lesion also 
appeared to depend on the duration of the disease 
process. Lymphocytic and monocytic cell intimation was 
usually more intense in areas with better preservation of 
normal tissue architecture than in areas with pronounced 
glial and mesenchymal reactions, and in such areas a rel- 
atively small number of lymphocytes was intermingled 
with a mass of foamy cells. Lymphocytes were confined 
mostly to the perivascular spaces and were often inter- 
mingled with macrophages. 
Parenchymal Tissue Damage 
The inflammation involved both the white and gray mat- 
ter, but the white matter was preferentially degenerated 
at the sites of inflammation. In long-standing lesions, both 
the myelin and the axon were equally degenerated and 
lost, and the tissue was largely replaced by glial scars 
seeded with numerous foamy cells, microglial cells, and 
a small number of lymphocytes. 
In inflammatory lesions, neurons were relatively well 
preserved and the number of large neurons did not seem 
to be reduced, although increased lipopigment content 
and various degrees of shrinkage of cell bodies commonly 
were seen in both the anterior and posterior horns. The 
neurons in the intermediolateral and Onuf’s nuclei also 
were in various states of degeneration, but the severity 
of neuronal degeneration in these nuclei did not exceed 
that in the anterior and posterior horns. 
Alteration of vascular walls also was conspicuous. 
Fibrous thickening of adventitia was most consistent, and 
a hyalinized change in small vessels also commonly was 
seen. Such changes in the vessel walls were not confined 
to the white matter; small vessels in the gray matter were 
equally affected, often accompanied by marked gliosis in 
the surrounding tissues. The endothelium, however, 
showed no appreciable changes, and no obstructive 
change was found in the parenchymal vessels. Frank tis- 
sue necrosis or cavity formation was found in none of 
these cases. 
Distribution of White Matter 
Degeneration in the Spinal Cord 
The lower thoracic cord, Th7- 12, was most severely and 
possibly initially involved in the disease process. Old 
lesions always were found in the lower thoracic cord, 
and the lesions in the upper thoracic and cervical seg- 
ments always appeared to be relatively new. 
In myelin stain preparations, symmetrical pallor of 
the lateral funiculi, particularly of the lateral pyramidal 
172 InternationalJoumaZ of Infectious Diseases / Volume 3, Number 3, 1999 
tract was found. The entire length of the lateral pyrami- 
dal tract was involved, but it was most severely degen- 
erated in the lower thoracic and upper lumbar segments. 
Involvement of the posterior funiculi was suspected 
in all cases. The severity and extent of myelin pallor in 
the posterior funiculus usually were mild and more vari- 
able than in the pyramidal tract. 
Lesions Outside the Spinal Cord 
Perivascular mononuclear cell infiltration in the brain was 
not uncommon, but usually it was not accompanied by 
any appreciable parcnchymal tissue damage. Similar mild 
perivascular cell infiltration was seen in the medulla 
oblongata in the cerebellum and the thalamus. Although 
the spinal nerve roots and peripheral nerves appeared 
to be spared in most cases, marked loss of the myelinated 
fibers was reported in the sum1 nerve, the sciatic nerve, 
and the cauda equina. 
Iwasaki concluded stating 
HAMKSP is a rare CNS manifestation of an autoimmune 
process associated with me persistent HTLV-I infection 
of T-lymphocytes rather than a direct consequence of 
virus invasion into CNS tissue. Because of the unusual 
chronic&y of the disease process, the classical histo- 
pathological features of acute parainfectious enceph- 
alomyelopathy are obviously modified, but perivenous 
inflammatory degeneration of the white matter, a char- 
acteristic of paminfectious diseases, is still retained in 
HAM/T% ‘Chronic progressive parainfectious myelo- 
pathy’, therefore appears to be the most appropriate 
term to describe this unusual situation. 
In the publication of Liberski and co11eagues,‘o1 the 
ultrastructural electron microscopy fmdings of TSP autop- 
sies were similar to those observed in human motor neu- 
ron diseases, especially amyotrophic lateral sclerosis and 
Werdnig-Hoffmann disease. These authors remarked on 
the accumulation of lipofuscin, the dystrophic neurites, 
the spheroids, and the chromatolitic neurons that are pre- 
sent in both diseases. It was interesting to note the phe- 
nomenon of glial bundles found in one of their cases. 
In the publication by Cartier et al, the macroscopic 
examination showed marked atrophy of the thoracic 
spine in two cases, mild atrophy in two cases, and no 
atrophy in the other two. lo3 The histology showed glial 
thickening with lymphocytic infiltrates. Demyelination of 
the lateral funiculus with frequent vacuolization of the 
myelin and degeneration of the corticospinal tracts was 
evident. 
The lower motor neurons depicted some degree of 
chromatolysis and pyknosis especially in the thoracic and 
lumbar regions. There was some loss of the smaller neu- 
rons (interneurons) and fibrillar gliosis. 
In most cases, the thalamus seemed to show a slight 
reduction of neurons, and some of them were overloaded 
with lipofuscin. In the thalamic area and internal capsule 
there were vessels with lymphocytic cuffing. The basal 
ganglia and hypothalamus showed no structural changes. 
In two cases, some neurofibrillary changes were seen in 
the motor cortex. 
The sacral and lumbar dorsal ganglia showed prolif- 
eration of satellite cells of the neurons in four cases and 
slight lymphocytic infiltration in two cases. The neurons 
appeared to be preserved, but some of them showed 
chromatolysis, pyknosis, or a pale cytoplasm. The histo- 
logic study of the median, sural, and sciatic nerves and 
nerve roots and muscles showed no abnormalities. 
Following is most of the “Discussion” from this excel- 
lent publication. lo3 
This clinicopathological study shows that TSP/HAM 
has a clearly defined pathological pattern. The clinical 
differences in these 6 TSP/HAM patients are related to 
the extension and severity of this pattern. The cases 
showed a close clinicopathological correlation. AU of 
them had lesions in the axons and myelin of the pyra- 
midal tract of the spinal cord, which followed an 
ascendant pattern similar to some degenerative dis- 
eases, as in familiar spastic paraparesis, with marked 
abnormalities in the lumbar and thoracic segments of 
the spinal cord that became less severe as the tract 
reached the cervical segments. Four cases had lesions 
in the Go& tract distributed in a descendant pattern, 
with maximal involvement in the cervical region and 
becoming negligible towards the caudal regions. 
The spinal cord lesions of patients with TSP/HAM, 
ascendant in the pyramidal tract and descendant in 
the posterior columns, have been interpreted else- 
where as demyelinating, either as a primary cytotoxic 
disorder or secondary to inflammatory or immuno- 
logical disorders. However, primary demyelinating dis- 
eases, either viral or inflammatory in origin, damage 
myelin in several areas, usually confluently and in a 
transverse fashion. Disorders that damage the myelin 
affect different systems simultaneously, such as in mul- 
tiple sclerosis or multifocal leukoencephalopathy. Cen- 
tral nervous system demyelinating diseases involve 
groups of oiigodendrocytes, and each oligodentrocyte 
myelinates several axons independent of their fum- 
tions. However, in TSP/HAhJ lesions, the myelin fol- 
lows the axons in a dying-back fashion (axial) that 
especially affects the longest axons. The lesions in the 
posterior columns also support the idea of an 
axomyelinic degeneration. The lesions of Go& tract 
in the cervical spinal cord are selective, affecting the 
longest axon from the legs. 
It seems unlikely that these parenchymal changes 
are secondary to vascular changes. Abnormal vessels 
with gross thickening of the adventitia were seen in 
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all patients, many of them with lymphocytic cuffs, 
especially in the spinal cord, brain stem, midbrain, thal- 
amus, and meninges, but were unrelated to the loca- 
tion or severity of the parenchymal damage. 
Furthermore, vascular changes are restricted to a pro- 
liferation on the adventitia, and we did not find vas- 
culitic changes such as necrosis of the vascular wall, 
endothelial proliferation, or ischemic lesions in the 
surrounding tissue in any of our cases. 
This study contributes to the idea that cerebral 
involvement is part of the TSP/HAM picture. In two 
cases that presented with intellectual impairment, 
demyelination of the subcortical and parathalamic 
areas without U fiber involvement was observed. 
All cases showed histological sialoadenitis. These 
findings seem to be part of the same disease and do 
not seem to be secondary to an immunological phe- 
nomenon. 
DISCUSSION 
It is well known that HTLV-I infection is an old phe- 
nomenon in most TSP/HAM endemic regions and that 
the high prevalence of TSP in such geographically sirni- 
lar foci as Tumaco, Colombia,1o5 Mahk in the Seychelles,lffi 
Lisala and Inongo,87,107 in Zaire (DRC), suggests the pres- 
ence of environmental factors. These regions are located 
near the equator. The initial TSP outbreak described in 
Jamaica was epidemic, and most patients were sugar cane 
workers.lo8 
Experimental TSP/HAM in Rats 
An argument that appears to favor the causal relation 
between HTLV-I and TSP/HAM is the development of 
TSP/HAM-like syndromes in rats after inoculation with 
HTLV-I.109-113 After a peer review of this impressive exper- 
imental work, some crucial observations cast doubt on 
these conclusions: 
1. The anatomopathologic findings of the TSP/HAM- 
like syndrome in WKA rats are quite different from 
those of human TSP/HAM and are unlikely to cause 
spa&city in the animals. 
2. The pathologic findings of those HTLV-I-infected rats 
correspond more to the ones found in the polio- 
encephalomyelopathy (PEM) of wild mice of lake 
Casitas (southern California) caused by an exogenous 
MuLyl’* and it is accepted that mice, rats, and humans 
carry endogenous retroviral sequences. 
3. Only 37 to 63% of the WKA rats and none of the 
F344 rats developed signs of human TSP/HAM.llo,lll 
4. One Wistar rat whose mother received blood from a 
PCR HTLV-I-seronegative TSP patient developed para- 
paresis, and this rat also was HTLV-I seronegative.l13 
Recently in Japan, some cases of slowly progressive 
spastic paraparesis associated with hepatitis B virus (HBV) 
without HTLV-I were seen. This new and interesting syn- 
drome was named hepatitis B virus-associated myelopa- 
thy (HBVAM).l15 
Neurolathyrism 
Neurolathyrism is a neurologic disorder caused by exces- 
sive ingestion of Lathyrus, or chick pea species. Lathyrism 
has been known since ancient times; epidemics have 
occurred in some regions, including Russia, southern 
Europe, the Mideast, and India, particularly during times 
of famine, when chick pea consumption increased. Lathy- 
rus sativus, L. cicera, and Vkia sativa are the species 
implicated. Horses, cattle, swine, and birds have been 
affected. 
Clinically, lathyrism often presents relatively rapidly 
after a prolonged period (months) of ingesting large 
amounts of the chick peas, often in the context of gen- 
eral malnutrition. Disease often commences with com- 
plaints of pain or cramps in the legs or in the region of 
the lumbar spine. Lower extremity weakness and sphinc- 
ter dysfunction then develop, soon evolving into perma- 
nent spastic paraparesis. The cramping pains and the 
sphincter dysfunction usually subside when the intoxi- 
cation ceases and spastic@ develops. 1 l6 
There are a few pathologic studies of lathyrism, but 
a report by Hirano et al confirms earlier descriptions of 
bilateral atrophy in the distal pyramidal tract in the lum- 
bar cord.‘l’ Additionally, there have been morphologic 
descriptions of degenerative changes in the spinocere- 
bellar tracts and dorsal columns. In concert, these data 
suggest a central nervous system (CNS) disease expressed 
most pronouncedly in the distribution of the longest CNS 
fibers. 
Konzo or Buka-Buka is an acute or chronic form of 
spastic paraparesis more common in tropical countries 
than in temperate climates. Deficiencies or toxicities due 
to primitive diets as well as infectious agents have been 
implicated. 118 Konzo is similar to lathyrism but differs 
from TSP/HAM and from lathyrism in its abrupt onset, 
nonprogressive course. Normal magnetic resdnance imag- 
ing scans of brain and spinal cord in severely affected 
patients provide evidence of selective damage of the 
upper motor neurons. All Konzo patients were seroneg- 
ative to retroviruses.119 
The possibility that the pathogenesis of TSP/HAM is 
secondary to an autoimmune process produced via mol- 
ecular mimicry recently has been postulated by E Gar- 
cia, a biologist at Valle University in Cali, Colombia, 
working with Max Essex of Harvard School of Public 
Health, Boston. Currently, this theory appears to be one 
of the best possible explanations for TSP/HAM and most 
HTLV-I-associated syndromes~1zo~121 This theory also could 
explain some of the ‘icontradictory” epidemiology of 
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TSP/HAM, and further, it would indicate the prevention 
and possible treatments of TSP/HAM. 
CONCLUSIONS 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
The etiopathogeneses of TSP/HAM are not yet clear. 
The etiology of HTLV-I-seronegative TSP is unknown. 
The anatomopathology of TSP/HAM depicts an 
anatomic distribution that follows the sensory and 
motor pathways of the CNS in a descending (sen- 
sory) or ascending (motor) pattern of the longest 
CNS fibers, and it shows an axomyelinic degeneration 
in a dying-back fashion. These changes suggest a 
toxic, metabolic, nutritional, or immunologic process. 
The neuropathology of TSP/HAM does not corre- 
spond to that seen in other viral diseases. 
The epidemiology of TSP/HAM suggests critical envi- 
ronmental unknown cofactors, and some cases could 
be neurolathyrism or Konzo. 
Some TSP/HAM cases may be due to unknown “lathy- 
rogenic” toxometabolic processes secondary to 
immunologic reactions. HTLV-I/II could cause 
bystander damage, or act as cofactors. 
The name HAM should be changed because in 
TSP/HAM there are anatomopathologic changes in 
the brain, cerebellum, and brain stem. 
The name TSP also should be changed because the 
disease is present outside the tropics. 
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